Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Y2k_fan who wrote (336)	3/27/1998 8:41:00 PM
From: Ray Tarke	Respond to of 2887

Future products with Great Value. The bifurcated OmniStent is a Y-shaped bifurcated stent designed for use in aortic bifurcation. However, small versions may be used at any branched blood vessel. The bifurcated version is also an endless stent overcoming the deficiencies of prior art in construction. ( However, it is unique in design as No other company has solved the dilemma of manufacturing and deploying a bifurcated stent ). All rely on a series of single stents, placed in close proximity, and usually requiring an access from each artery (lateral and contralateral femoral). This is very distressful to the patient requiring a surgical prep, artery puncture and catheter sheath on each side of the groin. Potentially it is twice as difficult, dangerous and time consuming to both patient and doctor as the bifurcated OmniStent. In addition, the Company has developed a process of reproducing the stents using photoetching which significantly reduces cost and production error. The Company's patent includes a proven biocompatible coating used to coat the interior surface of artificial hearts. This neutralized collagen compound is considered to be one of the most blood- and tissue-compatible biomaterials used to construct a smooth blood flow around the device. When applied as a thin film it provides a smooth, biochemically stable protein coating with non-pseudo intima properties, very little platelet adhesion, and high blood compatibility. In addition, when used as a substrate, the coating bonds easily with various anticoagulant molecules such as Heparin and phospholipids which are used to further reduce thrombosis. The Company has developed a concept for covering its stents with graft material and plans to file a patent on this process in the future. Being a long time Stockholder in ABMI is nice to see The coming future is very BRITE! Regards, R.T * I am sure this imfo has been provided by Jeff or Sri earlier.

To: Y2k_fan who wrote (336)	3/28/1998 1:55:00 PM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 2887

American BioMed has technologies that can save lifes: Six or seven years ago a vibrant young woman of nearly 70 had to see a new physician due to changes in her medical insurance. Her new physician, something of a geriatric specialist, diagnosed something that her own cardiologist had missed: Aortic Stenosis In layman's terms this is a narrowing of the largest artery on the body due to atherosclerosis(plaque or calcification built up inside the arteries). Her son in law took it on himself to do a little reading on the subject and found that the the condition was definitely life threatening but her cardiologist felt she would be fine. This active, witty and wonderful lady was only too happy to believe her cardiologist despite the fact that she herself had been nurse for many years. She continued her life the best she could despite shortness of breath and chest pain after minor exertion. Finally 2 years later it was decided that she should indeed have heart surgery before it was too late. Her heart surgeon explained to her son in law that due to the great deal of calcification around the aortic valve she was at high risk of a post operative stroke. The surgery was scheduled and performed replacing her aortic valve and putting the patient on coumadin post operatively to keep the blood thin and reduce the risk of a stroke. At first everything seemed to be going well after the surgery and the woman went home with her daughter and son in law to recover. She was told to walk as much as possible to speed her recovery but complained of pain and an tingling, itchy sensation in her legs(claudation). Two months later she was slowly slipping downhill and constantly complained about pain in her feet. Trip after trip to her physicians resulted in little or no help for what her physicians seemed to feel was pychosomatic. She continued to feel worse and worse, acting less and less like herself. She developed blisters on her toes despite being almost totally inactive. Less than a year later she passed away. Her final year on this earth was simply hell. Due to gangrene she had half of one foot removed and several toes on the other. A short trip to a retirement community became a trip to the hospital followed by trips to nursing homes and more hospital stays. Finally she seemed to be improving enough to leave the nursing home and return to a retirement community. Hours after she was taken off her coumadin(a blood thinner) she died of a massive stroke. The woman was my mother in law Adeline Moore. We had a special relationship that is the antithesis of every mother in law joke you ever heard. I feel that I let her down by not pushing her physician's to do more for her sooner. I loved her dearly and I miss her so much. American BioMed has a patented process that could eventually help to save surgical patients like my mother in law. The OmniFilter, or a product like it, could filter out the plaque that breaks away from an artery during these kinds of surgeries and potentially prevent strokes and blood clots. americanbiomed.com Go ABMI! Regards, Jeff

To: Y2k_fan who wrote (336)	5/21/1998 12:07:00 AM
From: Jeffrey L. Henken	Read Replies (2) \| Respond to of 2887

Over at Yahoo another buy out rumor of American BioMed appeared again today. This was my answer: JNJ + ABMI??? Yes we have all heard this rumor. Yes it is a possibility but I believe that these things are like birthday wishes... If you tell everyone then it won't come true! But just for the sake of argument why might it happen? ABMI's 27 patents, an outstanding 100% silicone catheter line, the OmniCath which should resume phase II testing soon, the Guidewire MicroFilter and other technologies that JNJ and no one else but the American BioMed division would then possess. Is this an actual possibility in reality? Lets look at some statements from JNJ and I'll ask you to draw your own conclusions: "Johnson & Johnson Outlines 'Platforms for Growth' Increases Dividend for 36th Consecutive Year biz.yahoo.com R&D Spending to Exceed $2.3 Billion in 1998 Larsen cited the importance of continuing to invest heavily in research and development, estimated an R&D expenditure of between $2.3 and $2.4 billion in 1998 (a record for Johnson & Johnson) and emphasized that R&D investment across the corporation is one of several fundamental strategies in the pursuit of growth. The others, he noted, are to continue to aggressively pursue licensing, outside investment and acquisition opportunities; as well as maintaining a commitment to productivity and cost efficiency." It could happen. It might happen. Just close your eyes and make a wish but for God sakes lets stop talking about it! In all seriousness American BioMed does possess some truly outstanding technology. Why they have not already been acquired is beyond me. Just because something has not yet occurred simply does not mean it will never happen. These kinds of things always seem to happen when you least expect it At the very least I expect to see this company form a strategic partnership or two before the year is out which will facilitate bringing products in R&D to market. Does this have to happen for American BioMed to succeed? Certainly not, especially with the $5 million equity line of credit but it sure will(I hope, I hope, I hope) Help! GO ABMI! Regards, Jeff GO ABMI!